Scarica l'app Stockscreener
0.38
1.58%
-0.0061
Dopo l'orario di chiusura:
.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cosmos Health Inc Borsa (COSM) Ultime notizie
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion - Morningstar
Cosmos Health Inc. (COSM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Price to sales ratio of Cosmos Health Inc – HAN:V67A - TradingView
Cosmos Health CosmoFarm Q2FY26 Results: Revenue tops $15M, hits $60M run rate - scanx.trade
COSM Continues to Grow Business - Yahoo Finance
COSM Forecast — Price Target — Prediction for 2027 - TradingView
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - USA Today
Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue - Investing.com
Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue By Investing.com - Investing.com South Africa
Robots and AI could let Cosmos Health's pharmacy distributor handle over $100 million in annual sales - Stock Titan
CosmoFarm | A Cosmos Health Company - YouTube
Cosmos Health Subsidiary Cana Laboratories Secures $20M Contract Manufacturing Pipeline (COSM) - GuruFocus
Cosmos Health’s Cana unit surpasses $20M CMO pipeline - Investing.com
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline - Corsicana Daily Sun
Cosmos Health Inc. (COSM) CMO Pipeline Implies $20M Revenue, $18M Gross Profit - TradingView
Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? - Stocktwits
Cosmos Health stock gains 14.79 percent after record revenue - AD HOC NEWS
Cosmos Health stock trades at USD 0.44 as filings remain central - AD HOC NEWS
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June - ACCESS Newswire
Cosmos Health stock moves on CCX0722 IP tokenization plan - AD HOC NEWS
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway - Newswire.com
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market - New Castle News
Cosmos Health subsidiary secures 5.2M unit manufacturing deal - Investing.com
Cosmos Health subsidiary secures 5.2M unit manufacturing deal By Investing.com - Investing.com India
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma - FinancialContent
Cosmos Health engages Prime Ledger for tokenized IP financing - Investing.com
Cosmos Health engages Prime Ledger for tokenized IP financing By Investing.com - Investing.com India
A weight-management capsule’s gel expands more than 100-fold. Cosmos Health proposes funding it without new shares. - Stock Titan
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com South Africa
Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar - TradingView
COSM Looks 10.4% Undervalued on GF Value™ Amid Contract Manufact - GuruFocus
Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine - Bitget
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - ACCESS Newswire
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - webull.com
Cosmos Health receives first orders for veterinary product line By Investing.com - Investing.com Nigeria
COSM Looks 8.2% Undervalued on GF Value™ Amid Challenging Fundam - GuruFocus
Cosmos Health receives first orders for veterinary product line - Investing.com
Cosmos Health buyback reaches 5.11 million shares under $5 million program - scanx.trade
Cosmos Health reports record revenue, retires $8M debt early By Investing.com - Investing.com Australia
Cosmos Health: A Company Transformed — 2026 Y - Moomoo
Cosmos Health Reaffirms 2029 Guidance - TradingView
Cosmos Health Q2FY26 Results: Revenue up 28.8% to $18.99M - scanx.trade
Cosmos Health reports record revenue, retires $8M debt early - Investing.com
Cosmos Health Inc. - Via Ritzau
Cosmos Health Reports Record H1 2026 Revenue, Strengthened Balance Sheet, and Major Global Expansion Milestones - Quiver Quantitative
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure, Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution from Conversions - marketscreener.com
Cosmos Health stock rises after $8 million note retirement - AD HOC NEWS
Cosmos Health retires $8M convertible note early By Investing.com - Investing.com UK
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions - kommunikasjon.ntb.no
Cosmos Health Retires $8 Million Convertible Note Early, Simplifies Capital Structure and Updates on Liquidity, Cash Requirements and Share Repurchases - Quiver Quantitative
Cosmos Health projects $6M revenue from Oliv18 supplement launch - Investing.com India
COSM Looks 33.4% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Cosmos Health projects $6M revenue from Oliv18 supplement launch By Investing.com - Investing.com Nigeria
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories - Barchart.com
Weekly Recap: Cosmos Health Q2 revenue gains and five‑year Innova Saudi deal - TradingView
Cosmos Health Inc. Projects Over $6 Million in Annual U.S. Revenue for Oliv18™ in 12 to 18 Months - Quiver Quantitative
Cosmos Health C-Sept PRO sales exceed $1.3 million at 72% margin - scanx.trade
9.43%
12.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):